Management of nephropathy in patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Management of nephropathy in patients with type 2 diabetes.

Management of nephropathy in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q34586189

about

Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula).Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.

P2860

Q34521231-BD0E6DF8-C055-495F-AE30-D9F6F7203EFF Q35124896-A3DAFDC2-FC5E-4CFE-929A-3DA438647A4E

P2860

Management of nephropathy in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q34586189

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Management of nephropathy in patients with type 2 diabetes.

@ast

Management of nephropathy in patients with type 2 diabetes.

@en

Management of nephropathy in patients with type 2 diabetes.

@nl

type

label

Management of nephropathy in patients with type 2 diabetes.

@ast

Management of nephropathy in patients with type 2 diabetes.

@en

Management of nephropathy in patients with type 2 diabetes.

@nl

prefLabel

Management of nephropathy in patients with type 2 diabetes.

@ast

Management of nephropathy in patients with type 2 diabetes.

@en

Management of nephropathy in patients with type 2 diabetes.

@nl

P1433

Q34586189-FC7D66DD-9B39-4851-82E0-8346D34C644B

P1476

Q34586189-FA0780D1-1507-441C-B7A3-8B15AA25B401

P2093

Q34586189-0A8701D0-3380-4591-93FC-AD28D7E5DB3D

Q34586189-24B2C206-80AF-4358-917D-D824D3D98FC5

Q34586189-43D6E1D1-BB39-4835-BD18-F5FFCD860725

Q34586189-AA8BB657-CC46-47E8-916E-B4BB95AACE13

Q34586189-C749839D-00C9-4F53-91FF-F2BB14D268A3

Q34586189-DCD50DEA-8F7D-45B9-9B51-9CDB1B4B8738

Q34586189-E0DA6139-D14C-4BA7-83AC-FB9B5E2F4922

P304

Q34586189-2CAF1B41-6FB7-4C4D-9000-C6D47CF8E598

P31

Q34586189-457EE772-1670-4548-80FF-271657FC18E0

P407

Q34586189-056740A9-BBE8-4E7D-937C-2B5FA2B79713

P433

Q34586189-36DC06CF-B2DE-4ED2-9C3E-5D15F8935487

P478

Q34586189-FB6BEDED-06E7-4182-B510-714705E61A50

P577

Q34586189-A85EC188-2492-475D-BEF7-EE935C87305A

P698

Q34586189-A6827805-1B2A-4BEF-B255-5F522AED025D

P921

Q34586189-C575B38F-B28D-45CF-A1EF-A5FA773B5431

P1433

Chinese Medical Journal

P1476

Management of nephropathy in patients with type 2 diabetes.

@en

P2093

Brian Tomlinson

http://www.w3.org/2001/XMLSchema#string

Clive S Cockram

http://www.w3.org/2001/XMLSchema#string

G Neil Thomas

http://www.w3.org/2001/XMLSchema#string

Hai-Lu Zhao

http://www.w3.org/2001/XMLSchema#string

Julian A J H Critchley

http://www.w3.org/2001/XMLSchema#string

Juliana C N Chan

http://www.w3.org/2001/XMLSchema#string

Wilson Leung

http://www.w3.org/2001/XMLSchema#string

P304

129-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11930647

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes